K243823: Control-IQ+ technology (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K243823 (Control-IQ+ technology, cleared 2025-02-24 for Tandem Diabetes Care, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K243823
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK243823
Cleared Device Trade / Generic NameControl-IQ+ technology
FDA Applicant on FilingTandem Diabetes Care, Inc.
FDA 3-Letter Product ClassificationProduct Code QJI
FDA Substantial Equivalence Decision Date2025-02-24
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Tandem Diabetes Care across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Tandem Diabetes Care, Inc., compare peer devices under FDA Product Code QJI, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.